These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34924456)

  • 1. Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan.
    Watanabe S; Shin JH; Morishita T; Takada D; Kunisawa S; Imanaka Y
    J Atheroscler Thromb; 2022 Nov; 29(11):1571-1587. PubMed ID: 34924456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends, Treatment Approaches, and In-Hospital Mortality for Acute Coronary Syndrome in Japan During the Coronavirus Disease 2019 Pandemic.
    Morishita T; Takada D; Shin JH; Higuchi T; Kunisawa S; Imanaka Y
    J Atheroscler Thromb; 2022 May; 29(5):597-607. PubMed ID: 33790127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in percutaneous coronary intervention practice in Japan during the COVID-19 outbreak: LIFE Study.
    Maeda M; Fukuda H; Kiyohara K; Miki R; Kitamura T
    Acute Med Surg; 2021; 8(1):e638. PubMed ID: 33738105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National survey of percutaneous coronary intervention during the COVID-19 pandemic in Japan: second report of the Japanese Association of Cardiovascular Intervention and Therapeutics.
    Ishii H; Amano T; Kohsaka S; Morino Y; Yokoi H; Ikari Y
    Cardiovasc Interv Ther; 2022 Apr; 37(2):264-268. PubMed ID: 33864606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.
    Dayoub EJ; Nathan AS; Khatana SAM; Wadhera RK; Kolansky DM; Yeh RW; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2021 Apr; 14(4):e006887. PubMed ID: 33719490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of policy alterations on elective percutaneous coronary interventions in Japan.
    Morishita T; Takada D; Shin JH; Kunisawa S; Fushimi K; Imanaka Y
    Heart; 2023 Mar; 109(8):612-618. PubMed ID: 36627183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on percutaneous coronary interventions in Portugal.
    Galvão Braga C; Araújo Gonçalves P; Cardoso P; Fiarresga A; Santos L; Domingues A; Costa M; Ferreira R; Duarte J; Seixo F; Campante Teles R; Pereira H; Silva JC; Fernandes R; Baptista J; Braga P; Costa J; Farto E Abreu P; Costa Ferreira P; Caires G; Martins D; Sousa P; Brum da Silveira J
    Rev Port Cardiol; 2023 Jan; 42(1):1-6. PubMed ID: 36043164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan　- Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
    Ishii H; Amano T; Yamaji K; Kohsaka S; Yokoi H; Ikari Y
    Circ J; 2020 Nov; 84(12):2185-2189. PubMed ID: 32963133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 pandemic early response measures on myocardial infarctions and acute cardiac care in Singapore.
    Lee SYA; Loh PH; Lau YH; Jiang Y; Liew BW; Lim PZY; Rastogi S; Tan WCJ; Ho HH; Yeo KK
    Int J Qual Health Care; 2023 Jun; 35(2):. PubMed ID: 37148306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York.
    Hannan EL; Wu Y; Cozzens K; Friedrich M; Tamis-Holland J; Jacobs AK; Ling FSK; King SB; Venditti FJ; Walford G; Berger PB; Kirtane AJ; Kamran M
    Am J Cardiol; 2021 Mar; 142():25-34. PubMed ID: 33301770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?
    Keskin G; Khalil E; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E022-E030. PubMed ID: 33635255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world use of intravascular ultrasound in Japan: a report from contemporary multicenter PCI registry.
    Kuno T; Numasawa Y; Sawano M; Abe T; Ueda I; Kodaira M; Suzuki M; Noma S; Nakamura I; Negishi K; Ishikawa S; Fukuda K; Kohsaka S
    Heart Vessels; 2019 Nov; 34(11):1728-1739. PubMed ID: 31129872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.
    Hess PL; Kini V; Liu W; Roldan P; Autruong P; Grunwald GK; O'Donnell C; Doll JA; Ho PM; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e203144. PubMed ID: 32315067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort.
    Kwok CS; Gale CP; Curzen N; de Belder MA; Ludman P; Lüscher TF; Kontopantelis E; Roebuck C; Denwood T; Burton T; Hains J; Deanfield JE; Mamas MA
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009654. PubMed ID: 33138626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    Hannan EL; Samadashvili Z; Cozzens K; Gesten F; Osinaga A; Fish DG; Donahue CL; Bass RJ; Walford G; Jacobs AK; Venditti FJ; Stamato NJ; Berger PB; Sharma S; King SB
    J Am Coll Cardiol; 2017 Mar; 69(10):1234-1242. PubMed ID: 28279289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland.
    Boeddinghaus J; Nestelberger T; Kaiser C; Twerenbold R; Fahrni G; Bingisser R; Khanna N; Tschudin-Sutter S; Widmer A; Jeger R; Kaufmann B; Pfister O; Sticherling C; Müller C; Osswald S; Zellweger MJ; Kühne M
    Int J Cardiol Heart Vasc; 2021 Feb; 32():100686. PubMed ID: 33335974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the COVID-19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis.
    Morishita T; Takada D; Shin JH; Higuchi T; Kunisawa S; Fushimi K; Imanaka Y
    ESC Heart Fail; 2022 Feb; 9(1):31-38. PubMed ID: 34913269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
    Gluckman TJ; Wilson MA; Chiu ST; Penny BW; Chepuri VB; Waggoner JW; Spinelli KJ
    JAMA Cardiol; 2020 Dec; 5(12):1419-1424. PubMed ID: 32766756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany.
    Oettinger V; Stachon P; Hilgendorf I; Heidenreich A; Zehender M; Westermann D; Kaier K; von Zur Mühlen C
    Clin Res Cardiol; 2023 Apr; 112(4):550-557. PubMed ID: 36198827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.